Oncology CME

Credits: 1.50 CME
Penn State College of Medicine
How I Think, How I Treat in the New Age of AML Care: Personal Perspectives on New Evidence and Innovative Therapeutics
December 24, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Rewriting Patient Care in Mantle Cell Lymphoma: How Innovative Therapy Is Poised to Challenge Conventional Treatment
December 24, 2020
Credits: 1.50 CME
Medical Learning Institute, Inc.
Exploring Antibody Therapy in ALL: How and Why to Integrate Antibody-Based Treatment Into Patient Management
December 24, 2020
Credits: 1.50 CME
Penn State College of Medicine
Building New Management Models for NHL Care: Tumor Board Insights on Innovative Therapeutics in FL and DLBCL
December 23, 2020
Credits: 1.50 CME
Penn State College of Medicine
Mapping the New Era in CLL Management: Precision Medicine and Patient Perspectives in Treatment-Naïve and Relapsed Disease
December 23, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
December 18, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Personalizing and Prolonging Care in GIST: Expert Guidance on Integrating New TKI Strategies
December 8, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Everything You Need to Know About Molecular Testing and Targeted Therapies in NSCLC: Essential Guidance for Modern Patient-Centered Precision Lung Cancer Care
November 30, 2020
Credits: 1.00 CME
PeerView Institute
How I Think, How I Treat: Individualizing RCC Therapy in the Era of Immuno-Oncology
November 20, 2020
Credits: 1.50
PeerView Institute
Emergency Department on Alert: Solving Oncologic Emergency Quandaries During the Immuno-Oncology Era and COVID-19 Pandemic
November 20, 2020
Credits: 1.50 CME / MOC / CNE / CPE
PeerView Institute
Immunotherapy in the Treatment Arsenal for Small Cell Lung Cancer, and Managed Care Implications for the Four Ps: Patient, Provider, Pharmacy, and Plan
November 12, 2020
Credits: 1.00 CME
PeerView Institute
Progressive Pathways: Recent Recommendations and Emerging Therapies for Treating NF1-Associated Tumors
November 5, 2020
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
At the Therapeutic Crossroads for RCC: Investigating the Current Applications, Controversies, and Future Use of Immunotherapy and Targeted Agents
October 22, 2020
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
The Pathology–Oncology Partnership in AML: Identifying and Treating the Diversity of Disease Subtypes
October 15, 2020
Credits: 1.00 CME / CNE
Medical Learning Institute, Inc.
A Clinician Guide to Tumor Treating Fields as a Fourth Modality in Cancer Treatment: Understanding the Science and Evidence and Implementing Critical Nursing Roles in Practice
October 5, 2020
Credits: 1.25 CME
Penn State College of Medicine
Achieving Innovation in CLL Care With BTK Inhibitors: Selection, Safety, and Sequencing Across the Disease Continuum
September 30, 2020
Credits: 1.00 CME
Penn State College of Medicine
The Rise of Novel Antibodies in Multiple Myeloma: Exploring the Present and Future of Antibody-Based Treatment From CD38 to BCMA
September 30, 2020
Credits: 1.00 CME
Medical Learning Institute, Inc.
Realizing the Potential of CDK 4/6 Inhibitor Therapy in Breast Cancer: An Examination of the Evidence That Is Informing Real-World Practice
September 30, 2020
Credits: 1.25 CME / CNE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach
September 24, 2020

Pages